Abstract：
:RAS is a small GTP binding protein mutated in approximately 30% human cancer. Despite its important role in the initiation and progression of human cancer, the underlying mechanism of RAS-induced human epithelial transformation remains elusive. In this study, we probe the cellular and molecular mechanisms of RAS-mediated transformation, by profiling two human ovarian epithelial cell lines. One cell line was immortalized with SV40 T/t antigens and the human catalytic subunit of telomerase (T29), while the second cell line was transformed with an additional oncogenic ras(V12) allele (T29H). In total, 32 proteins associated with RAS-mediated transformation have been identified using peptide mass fingerprinting. These protein targets are involved in several cellular pathways, including metabolism, redox balance, calcium signaling, apoptosis, and cellular methylation. One such target, the 40 kDa procaspase 4 is significantly upregulated at the protein level in RAS-transformed T29H cells, related directly to signaling through MEK, but not PI3 kinase. Cellular caspase 4 activity is, however, suppressed in the T29H cells, suggesting that the maturation process of caspase 4 is abrogated in RAS-transformed T29H cells. Consistent with this notion, transformed T29H cells were less susceptible to the toxic effects of anti-Fas antibody than were immortalized, nontransformed T29 cells, associated with less activation of caspase 4. This study demonstrates that functional proteomic analysis of a genetically defined cancer model provides a powerful approach toward systematically identifying cellular targets associated with oncogenic transformation.
journal_name
Oncogenejournal_title
Oncogeneauthors
Young T,Mei F,Liu J,Bast RC Jr,Kurosky A,Cheng Xdoi
10.1038/sj.onc.1208753subject
Has Abstractpub_date
2005-09-08 00:00:00pages
6174-84issue
40eissn
0950-9232issn
1476-5594pii
1208753journal_volume
24pub_type
杂志文章相关文献
ONCOGENE文献大全abstract：:In this study we have investigated DNA-protein interactions at an AP1-like motif of the neuropeptide tyrosine (NPY) promoter during in vitro differentiation of human neuroblastoma cells SH-SY5Y to mature nonproliferative sympathetic neuron-like cells. These neuroblast-like cells originate from the parental cell line S...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-08-01 00:00:00
abstract：:Treatment options for adenoid cystic carcinoma (ACC) of the salivary gland, a slowly growing tumor with propensity for neuroinvasion and late recurrence, are limited to surgery and radiotherapy. Based on expression analysis performed on clinical specimens of salivary cancers, we identified in ACC expression of the neu...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2012.377
更新日期：2013-08-08 00:00:00
abstract：:There is now much evidence to suggest that the p53 tumour suppressor protein functions to monitor the integrity of the genome. When DNA damage is detected, p53 suppresses cell growth to allow repair or directs the cell into apoptosis. The mechanism of action of p53 is as yet unclear but recent evidence has accumulated...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1995-10-05 00:00:00
abstract：:The autosomal dominantly inherited disease tuberous sclerosis (TSC) affects approximately 1 in 6000 individuals and is characterized by the development of tumors, named hamartomas, in different organs. TSC1, encoding hamartin, and TSC2, encoding tuberin are tumor suppressor genes responsible for TSC. Hamartin and tube...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1209812
更新日期：2007-01-25 00:00:00
abstract：:Membrane overexpression of the receptor tyrosine kinase ErbB-2 (MErbB-2) accounts for a clinically aggressive breast cancer (BC) subtype (ErbB-2-positive) with increased incidence of metastases. We and others demonstrated that nuclear ErbB-2 (NErbB-2) also plays a key role in BC and is a poor prognostic factor in ErbB...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2015.281
更新日期：2016-04-28 00:00:00
abstract：:Dasatinib, a dual Src family kinase and Abl inhibitor, is being tested clinically for the treatment of prostate cancer bone metastasis. Bidirectional interactions between osteoblasts and prostate cancer cells are critical in the progression of prostate cancer in bone, but the effect of dasatinib on osteoblasts is unkn...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.73
更新日期：2010-06-03 00:00:00
abstract：:Epithelial-to-mesenchymal transition (EMT), marked by the dissolution of cell-cell junctions, loss of cell polarity and increased cell motility, is one of the essential steps for prostate cancer metastasis. However, the underlying mechanism has not been fully explored. We report in this study that Shp2 is upregulated ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2015.184
更新日期：2016-03-10 00:00:00
abstract：:The transcription factor Cdx1 regulates intestine-specific gene expression and enterocyte differentiation. It has been hypothesized to play a role in regulating intestinal cell proliferation; however, the mechanism for this effect remains elusive. In a prior study, we demonstrated that Cdx1 expression reduced the prol...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206770
更新日期：2003-09-25 00:00:00
abstract：:Myc promotes both normal cell proliferation and oncogenic transformation through the activation and repression of target genes. The c-Myc-S protein is a truncated form of c-Myc that is produced in some cells from translation initiation at an internal AUG codon. We report that c-Myc-S and a similar truncated form of N-...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210734
更新日期：2008-02-21 00:00:00
abstract：:In this issue of Oncogene, Mollinedo and co-workers present promising evidence that cholesterol-sensitive signaling pathways involving lipid rafts can be therapeutically targeted in multiple myeloma. Because the pathways considered in their study are used by other types of tumor cells, one implication of this report i...
journal_title：Oncogene
pub_type： 评论,杂志文章
doi：10.1038/onc.2010.132
更新日期：2010-07-01 00:00:00
abstract：:The short isoform of single-minded 2 (SIM2s), a basic helix-loop-helix/PAS (bHLH/PAS) transcription factor, is upregulated in pancreatic and prostate tumours; however, a mechanistic role for SIM2s in these cancers is unknown. Microarray studies in prostate DU145 cells identified the pro-cell death gene, BNIP3 (Bcl-2/a...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2009.228
更新日期：2009-10-15 00:00:00
abstract：:Melanoma is the deadliest form of skin cancer with rising incidence, creating a significant health problem. We discovered increased expression of bone morphogenetic protein 6 (BMP6) in melanoma cells and tissues, and observed that BMP6 deficiency caused significantly delayed tumor onset and decelerated tumor progressi...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/s41388-018-0475-x
更新日期：2019-01-01 00:00:00
abstract：:Genetic lesions found in tumors are often targeted to the negative growth regulatory tumor suppressor genes. Much of our understanding of tumor suppressor gene function is derived from experimental manipulations in cultured cells. Recently, however, the generation of mice with germ line tumor suppressor gene mutations...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1202573
更新日期：1998-12-24 00:00:00
abstract：:BRCA1 is a tumour suppressor gene implicated in the predisposition to early onset breast and ovarian cancer. We have generated cell lines with inducible expression of BRCA1 to evaluate its role in mediating the cellular response to various chemotherapeutic drugs commonly used in the treatment of breast and ovarian can...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204712
更新日期：2001-09-27 00:00:00
abstract：:Pdcd4 is a novel transformation suppressor that is highly expressed in promotion-resistant (P-) mouse epidermal JB6 cells but not in susceptible (P+) cells. Overexpression of pdcd4 cDNA in stably transfected P+ cells rendered cells resistant to tumor promoter-induced transformation, indicating that elevated expression...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204137
更新日期：2001-02-08 00:00:00
abstract：:A lot of attention has been dedicated to investigate the role of the tyrosine kinase receptor MET in tumors. The acquired notion that cancer cells from different histological origin strictly rely on the engagement of this specific oncogene for their growth and survival has certainly justified the development and the u...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/onc.2016.36
更新日期：2016-10-20 00:00:00
abstract：:Resistance of pancreatic cancer to current treatments including radiotherapy remains a major challenge in oncology and may be caused by defects in apoptosis programs. Since 'inhibitor of apoptosis proteins' (IAPs) block apoptosis at the core of the apoptotic machinery by inhibiting caspases, therapeutic modulation of ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210502
更新日期：2007-10-25 00:00:00
abstract：:We have previously determined that the amplified DNA present in the HL60 promyelocytic leukaemia cell line contained 70 kb of continuous DNA sequences around the c-myc gene. In the work presented here we have further defined the HL60 amplicon and find it to be of the order of 160 kb and to contain a large region of DN...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-10-03 00:00:00
abstract：:Aromatase inhibitors (AIs) are the standard endocrine therapy for postmenopausal breast cancer; however, currently used biomarkers, such as, estrogen receptor-alpha/progesterone receptor (ERα/PR), predict only slightly more than half of the potential responders to AI treatment. To identify novel markers of AI responsi...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2013.553
更新日期：2015-01-15 00:00:00
abstract：:Aurora kinases are known to play a key role in maintaining mitotic fidelity, and overexpression of aurora kinases has been noted in various tumors. Overexpression of aurora kinase activity is thought to promote cancer development through a loss of centrosome or chromosome number integrity. Here we observed augmentatio...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208293
更新日期：2005-02-03 00:00:00
abstract：:Testicular germ cell tumours are classified into two major histological subgroups, seminomas and nonseminomas. All tumours display several recurrent chromosomal aberrations, but few target genes have been identified. Previous studies have shown that genome-wide hypermethylation of CpG islands is significantly more pre...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1205978
更新日期：2002-12-12 00:00:00
abstract：:Hexokinase-II (HK2) is a key enzyme involved in glycolysis, which is required for breast cancer progression. However, the underlying post-translational mechanisms of HK2 activity are poorly understood. Here, we showed that Proviral Insertion in Murine Lymphomas 2 (PIM2) directly bound to HK2 and phosphorylated HK2 on ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/s41388-018-0386-x
更新日期：2018-11-01 00:00:00
abstract：:Using a combination of raf and myc oncogenes co-expressed by the recombinant retrovirus J-2 we have generated and characterized a cell line which very efficiently supports the growth of B-cells and B-cell hybridomas. Murine spleen cells were cultured under in vitro immunization conditions favoring the short term proli...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1990-09-01 00:00:00
abstract：:The most frequent targets of genetic alterations in human lymphoid leukemias are transcription factor genes with essential functions in blood cell development. TAL1, LYL1, HOX11 and other transcription factors essential for normal hematopoiesis are often misexpressed in the thymus in T-cell acute lymphoblastic leukemi...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1210766
更新日期：2007-10-15 00:00:00
abstract：:Telomeres are stabilized, and telomeric DNA is replenished, by the action of the ribonucleoprotein reverse transcriptase telomerase. Telomere capping functions include the ability of telomeres to protect chromosome ends from cellular DNA-damage responses such as cell cycle arrest or apoptosis. This property of telomer...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1205082
更新日期：2002-01-21 00:00:00
abstract：:The transcription factor Ets-1 regulates the expression of several angiogenic and extracellular matrix remodeling factors, and might be implicated in disease progression of breast cancer. In the present study, the prognostic value of Ets-1 expression was assessed by quantitative real-time fluorescence RT-PCR in 123 sp...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206040
更新日期：2002-12-05 00:00:00
abstract：:Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional acti...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2013.508
更新日期：2014-12-11 00:00:00
abstract：:The balance of activities between the proto-oncogene phosphoinositide 3-kinase (PI3K) and the tumour suppressor gene PTEN has been shown to affect cellular growth and proliferation, as well as tumorigenesis. Previously, PTEN expression in the PTEN-null Jurkat T cell leukaemia line was shown to cause reduced proliferat...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206872
更新日期：2003-11-06 00:00:00
abstract：:A hallmark of human cancer is heterogeneity, reflecting the complex series of changes resulting in the activation of oncogenes coupled with inactivation of tumor suppressor genes. Breast cancer is no exception and indeed, many studies have revealed considerable complexity and heterogeneity in the population of primary...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2011.433
更新日期：2012-05-17 00:00:00
abstract：:Ovarian cancer is currently the second leading cause of gynecological malignancy and cisplatin or cisplatin-based regimens have been the standard of care for the treatment of advance epithelial ovarian cancers. However, the efficacy of cisplatin treatment is often limited by the development of drug resistance either t...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1209836
更新日期：2007-02-08 00:00:00
